Nitric oxide synthase in toxic epidermal necrolysis and Stevens-Johnson syndrome

Journal of Investigative Dermatology

Volumn 114, Issue 1, 2000, Pages 196-199

  Lerner, Lisa H ^a,b   Qureshi, Abrar A ^a   Reddy, Bhaskar V ^a   Lerner, Ethan A ^a  

^a Dermatology and Cutaneous Biology Research Center   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Apoptosis; Immunoenzyme techniques; Nitric oxide; Nitric oxide synthase; Polymerase chain reaction; Reverse transcriptase; Stevens Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ALLOPURINOL; AMFEBUTAMONE; ANTIBIOTIC AGENT; IBUPROFEN; LAMOTRIGINE; NITRIC OXIDE SYNTHASE; PHENYTOIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; FEMALE; HUMAN; KERATINOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 0034081054     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00816.x     Document Type: Article

References (27)

1. Bastuji-Garin S, Rzany B, Stem RS, Shear NH, Naldi L, Roujeau JC: Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92-96, 1993
2. Beckman JS, Koppenol WH: Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-37, 1996
3. Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA: Apoptosis and necrosis: rwo distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA 92:7162-7166, 1995
4. Bruch-Gerharz D, Ruzicka T, Kolb-Bachofen V: Nitric oxide in human skin: current status and future prospects. J Invest Dermatol 110:1-7, 1998
5. Brune B, von Knethen A, Sandau KB: Nitric oxide and its role in apoptosis. Eur J Pharmacol 351:261-272, 1998
6. Chlichlia K, Peter ME, Rocha M, et al: Caspase activation is required for nitric oxide-mediated, CD95 (APO-1/Fas) -dependent and independent apoptosis in human neoplastic lymphoid cells. Blood 91:4311-4320, 1998
7. Correia O, Delgado L, Ramos JP, Resende C, Torrinha JA: Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement. Arch Dermatol 129:466-468, 1993
8. Friedmann PS, Strickland I, Pirmohamed M, Park BK: Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 130:598-604, 1994
9. Gilliam AC, Whitaker-Menezes D, Korngold R, Murphy GF: Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease. J Invest Dermatol 107:377-383, 1996
10. Hoffman RA, Nussler NC, Gleixner SL, et al: Attenuation of lethal graft-versus-host disease by inhibition of nitric oxide synthase. Transplantation 63:94-91, 1997
11. Lancaster JR Jr: Simulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 91:8137-8141, 1994
12. Melino G, Bernassola F, Knight RA, Corasaniti MT, Nistico G, Finazzi-Agro A: S-nitrosylation regulates apoptosis. Nature 388:432-433, 1997
13. Michel T, Feron O: Nitric oxide synthases: which, where, how, and why? J Clin Invest 100:2146-2152, 1997
14. Nathan C: Inducible nitric oxide synthase: what difference does it make? J Clin Invest 100:2417-2423, 1997
15. Ormerod AD, Copeland P, Hay I, Husain A, Ewen SW: The inflammatory and cytotoxic effects of a nitric oxide releasing cream on normal skin. J Invest Dermatol 113:392-397, 1999
16. Paul C, Wolkenstein P, Adie H, Wechsler J, Garchon HJ, Revuz J, Roujeau JC: Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134:710-714, 1996
17. Qureshi AA, Hosoi J, Xu S, Takashima A, Granstein RD, Lerner EA: Langerhans cells express inducible nitric oxide synthase and produce nitric oxide. J Invest Dermatol 107:815-821, 1996a
18. Qureshi AA, Lerner LH, Lerner EA: From bedside to the bench and back. Nitric oxide and the cutis. Arch Dermatol 132:889-893, 1996b
19. Roujeau JC, Chosidow O, Saiag P, Guillaume JC: Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 23:1039-1058, 1990a
20. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Flechet ML, Girre JP: Toxic epidermal necrolysis (Lyell syndrome). Incidence and drug etiology in France, 1981-1985 [see comments]. Arch Dermatol 126:37-42, 1990b
21. Snyder SH, Bredt DS: Biological roles of nitric oxide. Sci Am 266:68-71, 74-7, 1992
22. Vanin AF: Biological role of nitric oxide: history, modern state, and perspectives for research. Biochemistry (Mosc) 63:731-733, 1998
23. Viard I, Wehrli P, Bullani R, et al: Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282:490-493, 1998
24. Villada G, Roujeau JC, Clerici T, Bourgault I, Revuz J: Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol 128:50-53, 1992
25. Weiss G, Schwaighofer H, Herold M, Nachbaur D, Wachter H, Niederwieser D, Wemer ER: Nitric oxide formation as predictive parameter for acute graft-versus-host disease after human allogeneic bone marrow transplantation. Transplantation 60:1239-1244, 1995
26. Wolkenstein P, Charue D, Laurent P, Revuz J, Roujeau JC, Bagot M: Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants. Arch Dermatol 131:544-551, 1995
27. Xu W, Charles IG, Liu L, Moncada S, Emson P: Molecular cloning and structural organization of the human inducible nitric oxide synthase gene (NOS2). Biochem Biophys Res Commun 219:784-788, 1996